TRELLUS HEALTH PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.65 GBX | 0.00% |
|
0.00% | -49.23% |
| Apr. 24 | Transcript : Trellus Health plc, Q4 2023 Earnings Call, Apr 24, 2024 | |
| Apr. 23 | EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat | AN |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 103.8 | 19.53 |
| Enterprise Value (EV) 1 | 71.81 | 0.4494 |
| P/E ratio | -14.3 x | -2.22 x |
| Yield | - | - |
| Capitalization / Revenue | 4,151,587,841 x | 1,085,246,251 x |
| EV / Revenue | 2,872,307,841 x | 24,968,473 x |
| EV / EBITDA | -12.2 x | -0.05 x |
| EV / FCF | -11,434,802 x | -54,342 x |
| FCF Yield | -0% | -0% |
| Price to Book | 2.94 x | 0.78 x |
| Nbr of stocks (in thousands) | 161,508 | 161,508 |
| Reference price 2 | 0.6426 | 0.1210 |
| Announcement Date | 5/10/22 | 5/26/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Net sales | - | 0.025 | 0.018 |
| EBITDA 1 | -1.522 | -5.892 | -8.622 |
| EBIT 1 | -1.524 | -5.902 | -8.687 |
| Operating Margin | - | -23,608% | -48,261.11% |
| Earnings before Tax (EBT) 1 | -1.524 | -5.902 | -8.81 |
| Net income 1 | -1.524 | -5.902 | -8.81 |
| Net margin | - | -23,608% | -48,944.44% |
| EPS 2 | -0.0181 | -0.0448 | -0.0545 |
| Free Cash Flow | - | -6.28 | -8.27 |
| FCF margin | - | -25,119% | -45,946.53% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 3/1/21 | 5/10/22 | 5/26/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Net Debt 1 | - | - | - |
| Net Cash position 1 | 3.68 | 32 | 19.1 |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -6.28 | -8.27 |
| ROE (net income / shareholders' equity) | - | -29.9% | -29.2% |
| ROA (Net income/ Total Assets) | - | -17.9% | -17.3% |
| Assets 1 | - | 32.93 | 50.88 |
| Book Value Per Share 2 | 0.0500 | 0.2200 | 0.1600 |
| Cash Flow per Share 2 | 0.0400 | 0.2000 | 0.1200 |
| Capex 1 | 0.02 | 0.08 | - |
| Capex / Sales | - | 324% | - |
| Announcement Date | 3/1/21 | 5/10/22 | 5/26/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -49.23% | 3.39M | |
| +13.11% | 3,161B | |
| +11.55% | 87.62B | |
| +7.38% | 79.59B | |
| -13.55% | 54.14B | |
| +25.92% | 48.15B | |
| -24.39% | 46.81B | |
| +35.49% | 47.69B | |
| +80.54% | 42B | |
| -6.24% | 25.77B |
- Stock Market
- Equities
- TRLS Stock
- Financials Trellus Health plc